NCT05226793View on ClinicalTrials.gov

Medication Use Evaluation for Enoxaparin in Hospitalized COVID-19 Patients

CompletedOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

November 17, 2021

Primary Completion Date

July 22, 2025

Study Completion Date

July 22, 2025

Conditions
Venous Thromboembolism
Trial Locations (1)

75082

Methodist Richardson Medical Center, Richardson

All Listed Sponsors
lead

Methodist Health System

OTHER

NCT05226793 - Medication Use Evaluation for Enoxaparin in Hospitalized COVID-19 Patients | Biotech Hunter | Biotech Hunter